COVID-19 exports to Australia↑123 times in a year

Trends in drug exports from January to April

Samsung Biologics is going to export Moderna vaccines in earnest

In the January-April period, exports of medicines to Australia surged more than 100 times compared to the same period last year-on-year.

 

In the pharmaceutical bio industry, it is interpreted that the moderna vaccine produced by Samsung BioLogics was exported to Australia in earnest, leading to an increase in total exports.

 

Exports to Germany, which was previously the largest exporter, fell by one-fifth in a year.

 

Exports to China and Japan also fell sharply.

 

As the COVID-19 crisis enters a calming phase, analysts say changes are coming to major drug exporters.

 

◆Export to Australia 3.4 billion → 420 billion won in a year, 95% of them are vaccines According to the Korea Customs Service on the 17th, exports of medicines from Korea to Australia from January to April this year were 325.1 million dollars.

 

Compared to $2.65 million (about 3.4 billion won) between January and April last year, it increased 123 times in a year.

 

Until the middle of last year, Korea did not export much medicine to Australia.

 

Before August last year, it was around 2 million dollars per month.

 

It was in September last year that there were signs of full-fledged change.

 

It exported 6.5 million dollars (about 8.3 billion won), more than three times more than usual.

 

In November, it increased further to $12.74 million (approximately 16.3 billion won) in November.

 

From December last year to February this year, it recorded more than 90 million dollars per month.

 

In particular, in March, it reached its highest point by exporting 130.21 million dollars over a month.

 

Exports in March were higher than annual exports of $126 million last year.

 

Monthly exports in April have fallen again to $349 million.

 

The pharmaceutical bio industry is paying attention to the fact that exports of medicines to Australia are concentrated in vaccines.

 

Exports of vaccines (HS code 3002.41) to Australia from January to April amounted to $314.36 million, accounting for 97% of all drug exports to Australia.

 

For the rest, it is maintained at the previous year's.

 

It is explained that Moderna vaccines produced by Samsung BioLogics were exported to Australia.

 

Yeonsu-gu, Incheon, is the only region in the country where vaccine exports have soared during this period.

 

It is the area where Samsung BioLogics is located.

 

◆81% of Germany, the largest pharmaceutical export country in the past.

 

"The base effect of panic buying" Exports of medicines to Germany plunged by one-fifth compared to the same period last year.

 

In the January-April period of this year, exports of medicines to Germany amounted to 192.91 million dollars, down 81% from 1.010.27 billion dollars during the same period last year.

 

Until last year, Germany was Korea's largest exporter of medicines for the past three years.

 

Last year alone, 1.76922 billion dollars of medicines were exported to Germany.

 

The pharmaceutical industry interprets that the rapid spread of COVID-19 in Europe has led to a decrease in drug exports to Germany.

 

In the early days of the spread of COVID-19, exports of medicines increased as Germany and other European countries competed to stock up on essential drugs, and the opposite situation is taking place this year when COVID-19 calms down.

 

Exports of medicines to Germany, which were $521.31 million in 2019, increased 3.5 times to $1.856.97 billion in 2020, the first year of COVID-19.

 

Last year, it recorded a slight decrease of $1.76922 billion.

 

In the process, the proportion of drug exports to Germany also increased significantly.

 

Germany accounted for 14.1% of all drug exports in 2019, but soared to 26.9% in 2020.

 

It decreased slightly to 21.8% last year, and fell to 8.8% from January to April this year.

 

◆47% decrease in China and 15% decrease in Japan In addition to Germany, exports of medicines to China and Japan also decreased significantly in a year.

 

In the January-April period, exports of medicines to China amounted to $45.31 million, nearly half of $84.77 million in the same period last year.

 

Exports to Japan also fell 15.2% from 161.25 million dollars to 136.68 million dollars in a year.

 

In the case of the two countries, it is analyzed that the decrease in local demand for medicines has affected the decrease in exports.